The DOI matches its Crossref record; 156 of the 162 references it cites were found in a registry or an index.
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Open accessAbstract
This is a repository copy of Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Metformin was prescribed in 8% and 44% of respondents at diagnosis and at follow-up clinic visits, respectively, to target insulin resistance and pre-diabetes risk, androgen production, cardiometabolic risk factors and reproductive concerns [67–70].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [69]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Metformin should be used for at least 3 months after completion depending on the patient’s ovulation recovery, androgen status, and metabolic clinical indicators [16,17].”
From Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial (2024) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Papaleo, E., Unfer, V., Baillargeon, J.-P., Fusi, F., Occhi, F., & De Santis, L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.01.088 · Cited by 197
Retracted- Retracted
Kazerooni, T., Ghaffarpasand, F., Kazerooni, Y., Kazerooni, M., & Setoodeh, S. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.04.022 · Cited by 47
RetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Self-citationYki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Self-citation
Research works printed but not linked: 15
- El-Biely, 2001, The use of metformin to augment the induction of ovulation in obese infertile patients with polycystic ovary syndrome, Middle East Fertility Society Journal, 6, 43
- Machado, 2012, Evaluation of the use of metformin for ovulation in patients with PCOS resistant to isolated use of clomiphene citrate, Brazilian Journal Assisted Reproduction, 16, 27
- Casimirri, 1997, Metformin improves insulin, body fat distribution, and androgens in obese women with and without the polycystic ovary syndrome, International Journal of Obesity, 21 Suppl 2, 61
- Chaudhry, 2016, Comparison between pioglitazone and metformin in terms of efficacy in patients with polycystic ovarian syndrome, Pakistan Journal of Medical and Health Sciences, 10, 574
- Morin-Papunen, 2010, Metformin improves pregnancy and live birth rates in women with polycystic ovary syndrome - a multicentre placebo-controlled randomised trial, 26th Annual Meeting of the European Society of Human Reproduction and Embryology, ESHRE Rome Italy, 25, i67
- Ramzy, 2003, The use of metformin in overweight and lean infertile patients with polycystic ovarian syndrome: a randomised controlled trial, Middle East Fertility Society Journal, 8, 143
- Santonocito, 2009, Comparison between clomiphene citrate and metformin for induction of ovulatory cycles in infertile nonobese women with polycystic ovary syndrome, Giornale Italiano di Ostetricia e Ginecologia, 31, 455
- Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Rautio, 2006, Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study, Human Reproduction, 21, 1400, 10.1093/humrep/dei505 · DOI
- Rautio, 2007, Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study, Fertility and Sterility, 87, 202, 10.1016/j.fertnstert.2006.05.061 · DOI
- Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014
- Schünemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention . Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
Cited by
Sorted by citations
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Lifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Self-citationOvulation: Parallels With Inflammatory Processes
Duffy, D. M., Ko, C. J., Jo, M., Brännström, M., & Curry, T. E. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00075 · Cited by 530
Fekadu, S., Alemayehu, E., Dewil, R., & der Bruggen, B. V. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.11.072 · Cited by 525
Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
Glueck, C. J., & Goldenberg, N. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.002 · Cited by 442
Metadata
- Authors
- Morley, L. C., Tang, T., Yasmin, E., Norman, R. J., & Balen, A. H.
- Affiliations
- Leeds General Infirmary (GB)
- Royal Jubilee Maternity Services (GB)
- University College Hospital (GB)
- The University of Adelaide (AU)
- Seacroft Hospital (GB)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-11-28
- Volume
- 2018
- Issue
- 2
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2982638573
- Cited by
- 296
- References
- 162
- Citations by year
- 2026: 14 · 2025: 34 · 2024: 31 · 2023: 43 · 2022: 45 · 2021: 39 · 2020: 33 · 2019: 28 · 2018: 18 · 2017: 4
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Funders
- Medical Research Council (MR/P002099/1)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- metformin, rosiglitazone, pioglitazone, D-chiro-inositol, polycystic ovary syndrome, subfertility, infertility treatment, ovulation induction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
